Patrick Vermersch

Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.

Philip Scheltens, Didier Leys, Frederik Barkhof et al. · Journal of Neurology Neurosurgery & Psychiatry · 1992 · 1.8K citations · Full text

Medicine, Neurology, Neuroscience +17

A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis

Gavin Giovannoni, Stuart D. Cook, Kottil Rammohan et al. · New England Journal of Medicine · 2010 · 1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +16

A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging

Philip Scheltens, Frederik Barkhof, Didier Leys et al. · Journal of the Neurological Sciences · 1993 · 928 citations

Medicine, Neurology, Radiology +12

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease

André Delacourte, Jean‐Philippe David, Nicolas Sergeant et al. · Neurology · 1999 · 809 citations

Medicine, Neurology, Neuroscience +17